GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.024x

Based on the latest financial reports, GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a cash flow conversion efficiency ratio of 0.024x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs362.20 Million ≈ $3.92 Million USD) by net assets (Rs15.40 Billion ≈ $166.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GLAXO stock market capitalisation for the company's overall valuation and market capitalisation.

GlaxoSmithKline Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how GlaxoSmithKline Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GlaxoSmithKline Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GlaxoSmithKline Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Explore GlaxoSmithKline Pharmaceuticals Limited (GLAXO) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hindustan Copper Limited NSE:HINDCOPPER	0.128x
Zhejiang Huazheng New Material SHG:603186	0.086x
AAC Technologies Holdings Inc F:A2XN	0.041x
Ryan Specialty Group Holdings Inc NYSE:RYAN	-0.137x
Rithm Capital Corp. NYSE:RITM	-0.013x
Glanbia PLC IR:GL9	0.021x
Tsingtao Brewery Co Ltd SHG:600600	0.032x
Kingnet Network Co Ltd SHE:002517	0.056x

Annual Cash Flow Conversion Efficiency for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. View GLAXO share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs19.51 Billion ≈ $211.03 Million	Rs12.90 Billion ≈ $139.50 Million	0.661x	+101.90%
2024-03-31	Rs17.78 Billion ≈ $192.24 Million	Rs5.82 Billion ≈ $62.94 Million	0.327x	+17.74%
2023-03-31	Rs17.41 Billion ≈ $188.31 Million	Rs4.84 Billion ≈ $52.37 Million	0.278x	-8.66%
2022-03-31	Rs26.63 Billion ≈ $287.99 Million	Rs8.11 Billion ≈ $87.68 Million	0.304x	-21.03%
2021-03-31	Rs14.99 Billion ≈ $162.12 Million	Rs5.78 Billion ≈ $62.50 Million	0.386x	+43.09%
2020-03-31	Rs18.21 Billion ≈ $196.89 Million	Rs4.90 Billion ≈ $53.05 Million	0.269x	+44.35%
2019-03-31	Rs21.40 Billion ≈ $231.41 Million	Rs3.99 Billion ≈ $43.19 Million	0.187x	-18.79%
2018-03-31	Rs20.57 Billion ≈ $222.49 Million	Rs4.73 Billion ≈ $51.13 Million	0.230x	+95.43%
2017-03-31	Rs20.07 Billion ≈ $217.03 Million	Rs2.36 Billion ≈ $25.52 Million	0.118x	+43.29%
2016-03-31	Rs16.96 Billion ≈ $183.42 Million	Rs1.39 Billion ≈ $15.05 Million	0.082x	-25.74%
2015-03-31	Rs24.44 Billion ≈ $264.32 Million	Rs2.70 Billion ≈ $29.21 Million	0.111x	-21.83%
2014-03-31	Rs19.90 Billion ≈ $215.18 Million	Rs2.81 Billion ≈ $30.42 Million	0.141x	-9.52%
2013-03-31	Rs20.07 Billion ≈ $217.03 Million	Rs3.14 Billion ≈ $33.91 Million	0.156x	-9.88%
2012-03-31	Rs19.36 Billion ≈ $209.34 Million	Rs3.36 Billion ≈ $36.30 Million	0.173x	-29.41%
2011-03-31	Rs19.52 Billion ≈ $211.06 Million	Rs4.79 Billion ≈ $51.84 Million	0.246x	-14.23%
2010-03-31	Rs17.86 Billion ≈ $193.16 Million	Rs5.12 Billion ≈ $55.32 Million	0.286x	+36.72%
2009-03-31	Rs15.76 Billion ≈ $170.39 Million	Rs3.30 Billion ≈ $35.69 Million	0.209x	-9.28%
2008-03-31	Rs13.81 Billion ≈ $149.33 Million	Rs3.19 Billion ≈ $34.48 Million	0.231x	+7.57%
2007-03-31	Rs12.05 Billion ≈ $130.29 Million	Rs2.59 Billion ≈ $27.97 Million	0.215x	-41.44%
2006-03-31	Rs9.53 Billion ≈ $103.08 Million	Rs3.49 Billion ≈ $37.78 Million	0.367x	+47.85%
2005-03-31	Rs9.24 Billion ≈ $99.90 Million	Rs2.29 Billion ≈ $24.77 Million	0.248x	--

About GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO India Drug Manufacturers - General

Market Cap

$5.20 Billion

Rs480.91 Billion INR

Market Cap Rank

#3485 Global

#157 in India

Share Price

Rs2838.80

Change (1 day)

+1.39%

52-Week Range

Rs2103.20 - Rs3106.40

All Time High

Rs3466.20